Initially characterized by symptoms such as fever, dyspnea, cough, myalgia, and fatigue, severe SARS-CoV-2 infections can lead to acute respiratory distress syndrome.
Additionally, a subset of COVID-19 patients has experienced persistent symptoms, known as long COVID, which can last for several months. These long-lasting symptoms often include chronic fatigue, dyspnea, chest and muscle pain, and various neurological disorders, such as brain fog, smell and taste dysfunction, and headaches. The mechanisms responsible for the development of long COVID and its diverse symptoms remain poorly understood.
Recent research has suggested a potential role of autoimmune processes in the manifestation of long COVID symptoms. Studies have identified the presence of autoantibodies (AAB) in individuals with long COVID, particularly those targeting extracellular antigens, immunomodulatory proteins like cytokines and chemokines, and G-protein-coupled receptors (GPCR).
Among these, functional autoantibodies (fAAB) have been found to play a significant role.
fAABs can activate specific receptors similarly to natural agonists, even though they bind to different receptor sites. This persistent activation of receptors may disrupt hormonal balance and contribute to the diverse symptoms seen in long COVID patients.
However, it remained unclear whether fAAB production was a direct consequence of SARS-CoV-2 infection. To address this question, researchers conducted a study using cattle and ferrets as animal models, as these species exhibit differing susceptibilities to SARS-CoV-2 infection. This investigation aimed to determine if experimental infection with SARS-CoV-2 in these animals led to the formation of fAAB, shedding light on potential mechanisms in humans.
Discussion
This relatively small sample size was justified by the complexity of the research objectives and the challenge of working with animal models that closely resemble human responses to the virus. These cattle produced fAAB activity only when they exhibited virus replication, while animals without virus replication showed no fAAB activity.
In ferrets, which are highly susceptible to SARS-CoV-2, most animals were infected with the virus, although they exhibited only mild clinical symptoms. Notably, these infected ferrets developed fAAB against GPCR, specifically binding to the β2-adrenoceptor and muscarinic M2 receptor, similar to patterns observed in humans with long COVID symptoms.
The timing of fAAB formation in animals following SARS-CoV-2 infection was notable. In both cattle and ferrets, fAABs were detectable in serum samples within weeks of experimental inoculation. This timeline mirrors the development of long COVID symptoms in humans, suggesting a potential link between early fAAB production and the subsequent onset of long-lasting symptoms.
The formation of fAAB against GPCR in response to SARS-CoV-2 infection in cattle and ferrets raises intriguing questions about the underlying mechanisms. Two possible explanations are proposed: structural similarities between SARS-CoV-2 and host GPCR receptors triggering autoantibody production, or the virus-induced inflammatory response contributing to autoantibody formation. Further research is needed to elucidate these mechanisms.
Notably, only cattle with virus replication generated fAAB against GPCR, hinting at the virus’s role in fAAB production. Virus infections often lead to elevated production of proinflammatory cytokines, and these cytokine storms have been observed in severe SARS-CoV-2 cases.
Conclusion
The study’s findings provide valuable insights into the formation of functional autoantibodies against GPCR in response to SARS-CoV-2 infection in animal models. While some limitations exist due to the challenges of working with animal models, this research highlights the potential role of the virus in autoantibody production and its relevance to long COVID.
Understanding the mechanisms behind fAAB production may help identify pathways and factors that could be targeted for intervention or prevention in the future. Additionally, the study suggests a possible connection between elevated proinflammatory cytokines and the development of these autoantibodies, which could have implications for SARS-CoV-2-related cardiovascular complications.
Ultimately, further research is needed to fully comprehend the complex interplay between SARS-CoV-2, the host’s immune system, and the development of functional autoantibodies.
reference link: https://www.mdpi.com/2227-9059/11/10/2668
